| Product Name | S-Deoxo Fulvestrant |
| Product Code | DA-F107-ap |
| Chemical name | S-Deoxo Fulvestrant |
| Synonyms | (7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (7α,17β); (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol; 7α-[9-(4,4,5,5,5-Pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol; |
| Impurity | NA |
| CAS Number | 153004-31-0 |
| Alternate CAS # | NA |
| Molecular form | C32H47F5O2S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 590.78 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | S-Deoxo Fulvestrant is an intermediate of fulvestrant, a breast cancer medication/drug. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
